Literature DB >> 23812579

Pelvic organ prolapse surgery with and without tension-free vaginal tape in women with occult or asymptomatic urodynamic stress incontinence: a randomised controlled trial.

Lore Schierlitz1, Peter L Dwyer, Anna Rosamilia, Alison De Souza, Christine Murray, Elizabeth Thomas, Richard Hiscock, Chahin Achtari.   

Abstract

INTRODUCTION: We set out to determine if insertion of a retropubic tension-free vaginal tape (TVT) sling at the time of pelvic organ prolapse surgery improves continence outcomes in women with pre-operative occult stress incontinence (OSI) or asymptomatic urodynamic stress incontinence (USI).
METHODS: We conducted a randomised controlled study of prolapse surgery with or without a TVT midurethral sling. The pre- and post-operative assessment at 6 months included history, physical examination and urodynamic testing. Quality of life (QOL) and treatment success was assessed with the UDI-6 SF, IIQ-7 SF and a numerical success score. The primary outcome was symptomatic stress urinary incontinence (SUI) requiring continence surgery (TVT) at 6 months. Long-term follow-up continued to a minimum of 24 months. Secondary outcomes were quality of life parameters.
RESULTS: Eighty women received prolapse surgery alone (n = 43) or prolapse surgery with concurrent TVT (n = 37). Six months following prolapse surgery 3 out of 43 (7 %) patients in the no TVT group requested sling surgery compared with 0 out of 37 (0 %) in the TVT group (ARR 7 % [95 %CI: 3 to 19 %], p = 0.11). After 24 months there was one further participant in the no TVT group who received a TVT for treatment of SUI compared with none in the TVT group (4 out of 43, 9.3 % versus 0 out of 37; ARR 9.3 % [95 %CI: -1 to 22 %], p = 0.06). Both groups showed improvement in QOL difference scores for within-group analysis, without difference between groups.
CONCLUSION: These results support a policy that routine insertion of a sling in women with OSI at the time of prolapse repair is questionable and should be subject to shared decision-making between clinician and patient.

Entities:  

Mesh:

Year:  2013        PMID: 23812579     DOI: 10.1007/s00192-013-2150-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Predicting postoperative urinary incontinence development in women undergoing operation for genitourinary prolapse.

Authors:  A Bergman; P P Koonings; C A Ballard
Journal:  Am J Obstet Gynecol       Date:  1988-05       Impact factor: 8.661

2.  Surgery for genitourinary prolapse and stress incontinence: a randomized trial of posterior pubourethral ligament plication and Pereyra suspension.

Authors:  M Colombo; A Maggioni; S Scalambrino; D Vitobello; R Milani
Journal:  Am J Obstet Gynecol       Date:  1997-02       Impact factor: 8.661

3.  Randomized prospective comparison of needle colposuspension versus endopelvic fascia plication for potential stress incontinence prophylaxis in women undergoing vaginal reconstruction for stage III or IV pelvic organ prolapse. The Continence Program for Women Research Group.

Authors:  R C Bump; W G Hurt; J P Theofrastous; W A Addison; J A Fantl; J F Wyman; D K McClish
Journal:  Am J Obstet Gynecol       Date:  1996-08       Impact factor: 8.661

4.  Prevalence of abnormal urodynamic test results in continent women with severe genitourinary prolapse.

Authors:  B A Rosenzweig; S Pushkin; D Blumenfeld; N N Bhatia
Journal:  Obstet Gynecol       Date:  1992-04       Impact factor: 7.661

5.  A midurethral sling to reduce incontinence after vaginal prolapse repair.

Authors:  John T Wei; Ingrid Nygaard; Holly E Richter; Charles W Nager; Matthew D Barber; Kim Kenton; Cindy L Amundsen; Joseph Schaffer; Susan F Meikle; Cathie Spino
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

6.  Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.

Authors:  J K-S Lee; P L Dwyer; A Rosamilia; Y N Lim; A Polyakov; K Stav
Journal:  BJOG       Date:  2011-03-10       Impact factor: 6.531

7.  A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence.

Authors:  U Ulmsten; C Falconer; P Johnson; M Jomaa; L Lannér; C G Nilsson; I Olsson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 8.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

9.  Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence.

Authors:  Linda Brubaker; Ingrid Nygaard; Holly E Richter; Anthony Visco; Anne M Weber; Geoffrey W Cundiff; Paul Fine; Chiara Ghetti; Morton B Brown
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

10.  The risk of developing urinary stress-incontinence after vaginal repair in continent women. A clinical and urodynamic follow-up study.

Authors:  E Borstad; T Rud
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

View more
  13 in total

1.  Should we combine vaginal prolapse surgery with continence surgery?

Authors:  J Marinus van der Ploeg; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2018-11-08       Impact factor: 2.894

Review 2.  Heterogeneity in post-intervention prolapse and urinary outcome reporting: a one-year review of the International Urogynecology Journal.

Authors:  Dobrochna Globerman; Magali Robert
Journal:  Int Urogynecol J       Date:  2015-05-06       Impact factor: 2.894

Review 3.  Stress incontinence surgery at the time of prolapse surgery: mandatory or forbidden?

Authors:  Ashley B King; Howard B Goldman
Journal:  World J Urol       Date:  2015-05-20       Impact factor: 4.226

Review 4.  Should prophylactic anti-incontinence procedures be performed at the time of prolapse repair? Systematic review.

Authors:  Priscila Katsumi Matsuoka; Aparecida Maria Pacetta; Edmund Chada Baracat; Jorge Milhem Haddad
Journal:  Int Urogynecol J       Date:  2014-10-28       Impact factor: 2.894

5.  External validation of de novo stress urinary incontinence prediction model after vaginal prolapse surgery.

Authors:  Jordi Sabadell; Sabina Salicrú; Anabel Montero-Armengol; Núria Rodriguez-Mias; Antonio Gil-Moreno; Jose L Poza
Journal:  Int Urogynecol J       Date:  2018-11-15       Impact factor: 2.894

6.  Is urodynamics necessary to identify occult stress urinary incontinence?

Authors:  Susane Mei Hwang; Luís Gustavo Morato de Toledo; Silvia da Silva Carramão; Armando Brites Frade; Andre Costa Matos; Antonio Pedro Flores Auge
Journal:  World J Urol       Date:  2018-06-05       Impact factor: 4.226

7.  Mesh complications and failure rates after transvaginal mesh repair compared with abdominal or laparoscopic sacrocolpopexy and to native tissue repair in treating apical prolapse.

Authors:  Vani Dandolu; Megumi Akiyama; Gayle Allenback; Prathamesh Pathak
Journal:  Int Urogynecol J       Date:  2016-08-25       Impact factor: 2.894

Review 8.  Incidence and Management of De Novo Lower Urinary Tract Symptoms After Pelvic Organ Prolapse Repair.

Authors:  Henry Tran; Doreen E Chung
Journal:  Curr Urol Rep       Date:  2017-09-12       Impact factor: 3.092

9.  Role of urodynamics before prolapse surgery.

Authors:  Maurizio Serati; Ilias Giarenis; Michele Meschia; Linda Cardozo
Journal:  Int Urogynecol J       Date:  2014-10-15       Impact factor: 2.894

10.  Vaginal prolapse repair with or without a midurethral sling in women with genital prolapse and occult stress urinary incontinence: a randomized trial.

Authors:  J Marinus van der Ploeg; Katrien Oude Rengerink; Annemarie van der Steen; Jules H Schagen van Leeuwen; C Huub van der Vaart; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2016-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.